CVRX
CVRx Inc.
$8.37
$0.00(0.00%)
52
Overall
50
Value
66
Tech
42
Quality
Market Cap
$248.91M
Volume
164.62K
52W Range
$4.30 - $12.35
Target Price
$11.17
Company Overview
| Mkt Cap | $248.91M | Price | $8.37 |
| Volume | 164.62K | Change | +0.00% |
| P/E Ratio | -4.2 | Open | $8.94 |
| Revenue | $51.3M | Prev Close | $8.37 |
| Net Income | $-60.0M | 52W Range | $4.30 - $12.35 |
| Div Yield | N/A | Target | $11.17 |
| Overall | 52 | Value | 50 |
| Quality | 42 | Technical | 66 |
No chart data available
About CVRx Inc.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Sector: Industrials
Industry: Surgical and Medical Instrument Manufacturing
Latest News
CVRx’s BENEFIT-HF Trial: New Heart Failure Study Sets Up a Key Catalyst for Investors
TipRanks Clinical-Trials-Auto-Generated Newsdesk•19 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVRX | $8.37 | 0% | 164.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |